[ad_1]
[Yakarta, 4o Reuters]Indonesia, which is preparing for the large-scale inoculation of the new coronavirus vaccine, prioritizes the inoculation of working generations over the elderly, and aims to rapidly acquire massive immunity and revitalize the economy. It is a plan. Its success or failure will attract the attention of other countries.
Some countries, such as the United States and the United Kingdom, have already started vaccinating older people who are prone to becoming seriously ill due to new corona infection.
However, the Indonesian method inoculates the production-age population between the ages of 18 and 59, following the front-line medical workers and civil servants. List the benefits and risks that experts think of this method.
The Indonesian government is planning a large-scale inoculation of the “Coronabac” vaccine developed by Kakou Holding Biotechnology (Sinobac Biotech) of China. The government explains that there is not yet enough data to show that the corona back is effective for older people. This is because the country is conducting clinical trials (clinical trials) targeting people ages 18 to 59.
A senior Health Ministry official said he was awaiting recommendations from drug regulators on vaccination plans for the elderly.
The vaccine, which the United Kingdom and the United States have begun to inoculate, was jointly developed by Pfizer in the United States and Biontech in Germany, and has proven to be effective across generations. However, Indonesia is initially only available in Corona Bac.
Indonesia has a supply contract with Shinobak for 125.5 million times, and has already brought 3 million times to the country. Shipments of the Pfizer Union vaccine to Indonesia are expected to begin in the third quarter. Distribution of the vaccines developed by Astra Zeneca and the University of Oxford will begin in the second quarter.
The Indonesian plan does not have a positive effect on mortality, the foreword of which was Professor Peter Kolignon of the Australian National University (Infectious Diseases): “I don’t think we can stipulate what is correct and doctrine.” Still, I hope it can slow down the spread of the infection. “It is significant that Indonesia’s path is different from that of the West, because we know that its strategy could have a more dramatic effect than Europe and the United States. However, the answer is. No one is getting it right now.”
Professor Dale Fisher of Yong Lu Lin School of Medicine, National University of Singapore also understands the validity of the Indonesian method. “The younger generation is generally more active, more social and more mobile, so it should be possible to reduce the rate of infection in the area to inoculate the elderly. But of course the elderly are more seriously ill.” Given the high risk of mortality and mortality, there is another reason to prioritize older people. Both methods have their benefits. “
<¿Conduce a una rápida adquisición masiva de inmunidad?>
The Indonesian government hopes that the immunity of the population can be obtained quickly if the population that is more socially active and engaged in economic activities is vaccinated first.
Health Minister Budi said that 181.5 million people, or about 67% of the total population, would need to be vaccinated to get massive immunity, about 400 million, assuming two vaccines per person and a 15% clearance rate. . He said he had to get 27 million doses.
However, some experts caution that further research is essential on whether or not to infect others with the virus after vaccination. It is doubtful that this method allows the acquisition of massive immunity.
“There is a risk of infecting others (even after vaccination),” said the director of the Indonesian Society for Medical Economics.
<¿Apoya la recuperación económica?>
According to economists, if about 100 million people are successfully vaccinated, economic activities such as consumption and production are more likely to revive, which will be a force to improve the economy.
Faisal Luckman, an economist at Bank Mandili, says that the population of production age between the ages of 18 and 59 has greater consumption needs than other generations. Since domestic consumption accounts for more than 50% of the Indonesian economy, it is safe to prioritize vaccinating the population of production age to support a faster economic recovery.
On the other hand, if the number of newly infected people continues to rise, there is a risk of weakening people’s confidence in the future, he said.
Last year’s Indonesian economy fell into recession for the first time in more than 20 years due to the disaster of the new crown, and the government estimates that it has slumped to growth of minus 2.2%.
